A detailed history of Tradewinds Capital Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 50 shares of BIIB stock, worth $7,451. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 50 -0.0%
Holding current value
$7,451
Previous $11,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 23, 2021

BUY
$242.95 - $284.63 $12,147 - $14,231
50 New
50 $14,000
Q1 2020

May 11, 2020

SELL
$268.85 - $341.04 $8,334 - $10,572
-31 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$220.06 - $304.07 $6,821 - $9,426
31 New
31 $9,000
Q4 2018

Jan 31, 2019

SELL
$278.5 - $352.75 $2,785 - $3,527
-10 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$293.51 - $383.83 $2,935 - $3,838
10 New
10 $4,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Tradewinds Capital Management, LLC Portfolio

Follow Tradewinds Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds Capital Management, LLC with notifications on news.